Back to search
Sojourn Therapeutics Limited
16591284
active
ltd
england wales
Health Score
65 / 100
Some Concerns
25/30
Filing
0/30
Financial
40/40
Risk
No risk factors detected.
Details
167-169 Great Portland Street, 5th Floor, London, W1W 5PF
Incorporated 18/07/2025
Compliance
Next accounts due
18/04/2027
On track
Confirmation statement
Last: 17/07/2026
Due 31/07/2027
On track
Industry
72110
Research and experimental development on biotechnologyOfficers
Joseph John Wilson
secretary · Since 18/07/2025
Professor Tuomas Pertti Jonathan Knowles
director · Since 18/07/2025
DIRECTOR
BRITISH · ENGLAND
Also on 3 other boards
Mr George Kelly Martin
director · Since 18/07/2025
DIRECTOR
AMERICAN · UNITED STATES
Also on 3 other boards
Joseph John Wilson
secretary · Since 18/07/2025
Persons with Significant Control
Samuel Cohen
25–50% shares
25–50% votes
British · England
Notified 18/07/2025
Professor Tuomas Pertti Jonathan Knowles
25–50% shares
25–50% votes
British · England
Notified 18/07/2025
Mr George Kelly Martin
Significant control
American · United States
Notified 18/07/2025
Change History
status → active
2026-07-07Active
type → ltd
2026-07-07Private Limited Company
address line1 → 167-169 Great Portland Street
2026-07-07167-169 GREAT PORTLAND STREET
post town → London
2026-07-07LONDON